As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, ...

In addition to rolling out new health policy priorities and structural changes, President Trump and his administration have ...

hearX CEO and co-founder Nic Klopper will serve as CEO for LXE Hearing, with Eargo's COO and interim CEO Bill Brownie assuming the role of COO.

Perceptive has introduced a structured approach that integrates imaging and Randomization Trial Supply Management (RTSM) services to support pharmaceutical and biotech companies in clinical research.

Clinical trials are essential in bringing innovative treatments to the market, but managing them efficiently requires cutting-edge technology. This is where IRT clinical trial companies play a crucial ...

Discover key insights from Curis, Inc.'s Q4 2024 earnings call, highlighting promising trial results, regulatory alignment, and extended financial runway.

The global human organoid market has garnered considerable attention in recent years, emerging as one of the most promising ...

Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...

"With the introduction of administrative data in Truveta Data and powerful new capabilities in Truveta Studio, Truveta can help researchers accelerate therapy development and adoption, while improving ...

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.